Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jul 29 2019

Full Issue

Tens Of Thousands Of Dollars' Worth Of Contraception May Have To Be Destroyed Under Title X Rule Changes

Clinic operators say they may have to return or destroy IUDs, hormonal patches, NuvaRings and birth control pills if they leave the federal family planning program. And since Title X also serves people who want to become pregnant, stocks of hormone treatments might have to be tossed as well.

Politico: Clinics Exiting Family Planning Program May Have To Destroy Contraceptives

Health clinics that quit the federal family planning program over new Trump administration anti-abortion rules may have to destroy or return tens of thousands of dollars of contraceptives and other medications. Federal health officials confirmed to POLITICO that clinics might need to get rid of drugs, intrauterine devices and other treatments they bought at a discount while part of the Title X program, a long-standing requirement that's catching some providers by surprise as they weigh whether to comply with new rules that, among other things, forbid abortion referrals. (Roubein and Ollstein, 7/26)

In other women's health news —

The Washington Post: NIH Issues Strict New Requirements For Fetal Tissue Research Funding

The National Institutes of Health issued instructions on Friday for how scientists seeking grants for research using fetal tissue must comply with recent Trump administration restrictions on federal funding of such studies. The new requirements triggered an immediate outcry from leaders in the field. In a notice spelling out the rule changes, NIH says that all grant applications and renewals for research relying on tissue collected from elective abortions must provide a detailed justification, documenting why no alternative methods could accomplish the same research goals. (Goldstein, 7/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF